Formoterol
This long-acting beta-2 agonist bronchodilator relaxes and widens the airways for up to twelve hours, providing sustained relief of breathing difficulties in asthma and COPD. It is typically used as a maintenance treatment, often in combination with an inhaled corticosteroid.
Peso molecular
344,4000 g/mol
LogP
1,80
TPSA
90,80 Ų
Regla de cinco de Lipinski
Cumple
Áreas terapéuticas
Mecanismo de acción
Binds to intracellular glucocorticoid receptors, translocating to the nucleus to modulate gene transcription. This suppresses multiple inflammatory genes encoding cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory proteins.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Binds to intracellular glucocorticoid receptors, translocating to the nucleus to modulate gene transcription. This suppresses multiple inflammatory genes encoding cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory proteins.
Estructura 2D
Cite this structure
Embed this structure
SMILES
COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1
InChI
InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)
Molecular Formula
C19H24N2O4
HBD / HBA
4 / 5
Enlaces Rotables
8
Átomos Pesados
25
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Preguntas frecuentes
This long-acting beta-2 agonist bronchodilator relaxes and widens the airways for up to twelve hours, providing sustained relief of breathing difficulties in asthma and COPD. It is typically used as a maintenance treatment, often in combination with an inhaled corticosteroid.
Binds to intracellular glucocorticoid receptors, translocating to the nucleus to modulate gene transcription. This suppresses multiple inflammatory genes encoding cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory proteins.
Yes, Formoterol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1256786. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 3410. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="formoterol"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/formoterol/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/formoterol/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/formoterol/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="formoterol"></drugfyi-drug>